Correspondence 0001193125-23-154290 from Harpoon Therapeutics, Inc. (CIK 0001708493)
Harpoon Therapeutics, Inc. (CIK 0001708493)
Date: May 25, 2023 · CIK: 0001708493 · Accession: 0001193125-23-154290
AI Filing Summary & Sentiment
File numbers found in text: 333-272064
Letter
Re: Harpoon Therapeutics, Inc.
May 25, 2023
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Mr. Arzhang Navai
Registration Statement on Form S-3
File No. 333-272064
Acceleration Request
Requested Date: May 30, 2023
Requested Time: 4:00 PM Eastern Daylight Time
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the Registration Statement on Form S-3 (File No. 333-272064) (the “Registration Statement”) to become effective on Tuesday, May 30, 2023 at 4:00 p.m. Eastern Daylight Time, or as soon as practicable thereafter, or at such later time as the Registrant may orally request via telephone call to the staff of the Commission (the “Staff”). The Registrant hereby authorizes each of Courtney M.W. Tygesson and Marina Remennik of Cooley LLP, counsel to the Registrant, to make such request on its behalf.
Once the Registration Statement has been declared effective, please orally confirm that event with Courtney M.W. Tygesson of Cooley LLP, counsel to the Registrant, at (312) 881-6680, or in her absence, Marina Remennik at (650) 843-5124.
Very truly yours,
HARPOON THERAPEUTICS, INC.
Show Raw Text
CORRESP
1
filename1.htm
CORRESP
May 25, 2023
VIA EDGAR
U.S. Securities and Exchange
Commission
Division of Corporation Finance
100 F Street,
N.E.
Washington, D.C. 20549
Attn: Mr. Arzhang Navai
Re: Harpoon Therapeutics, Inc.
Registration
Statement on Form S-3
File No. 333-272064
Acceleration Request
Requested Date:
May 30, 2023
Requested Time: 4:00 PM Eastern Daylight Time
Ladies and Gentlemen:
In accordance with Rule 461 under the
Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the
Registration Statement on Form S-3 (File No. 333-272064) (the “Registration Statement”) to become effective on Tuesday, May 30, 2023 at
4:00 p.m. Eastern Daylight Time, or as soon as practicable thereafter, or at such later time as the Registrant may orally request via telephone call to the staff of the Commission (the “Staff”). The Registrant hereby
authorizes each of Courtney M.W. Tygesson and Marina Remennik of Cooley LLP, counsel to the Registrant, to make such request on its behalf.
Once the
Registration Statement has been declared effective, please orally confirm that event with Courtney M.W. Tygesson of Cooley LLP, counsel to the Registrant, at (312) 881-6680, or in her absence, Marina Remennik
at (650) 843-5124.
Very truly yours,
HARPOON THERAPEUTICS, INC.
By:
/s/ Julie Eastland
Julie Eastland
President and Chief Executive Officer
cc:
Courtney M.W. Tygesson, Cooley LLP
Marina Remennik, Cooley LLP